Older Americans with metastatic breast, colorectal, lung, or prostate cancer are spending an increasing amount of time in the ...
Early and sustained ctDNA clearance in early breast cancer treated with neoadjuvant HER2-targeted therapy tracks closely with pathologic complete response to treatment and 3-year outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback